Early voting for Campaign 2026 began in MN, SD and VA September 18, followed by VT September 19 and IL September 24. Today, early voting starts in CA, MT and NE followed by IN, NM and OH tomorrow, and AZ Wednesday. By October 22, 35 other states will be hosting early voting leaving voters in AL, MS, and NH a choice of election day (November 3) unless they’re among the 35 million expected to vote by mail this year.
In all of this, healthcare will be on the ballot. Per Pew, KFF and Gallup polling, healthcare is the second most important issue to voters this year behind overall costs of living (gas, food, and housing). Per KFF:
- 9 of 10 voters say healthcare affordability is an important issue this year.
- 66% of adults say they worry about paying their healthcare bills.
- Among rural voters and seniors, access to doctors and services and affordability for out-of-pocket health expenses (including insurance premiums) are their biggest concerns.
- Among Republican voters, program integrity (waste, fraud) is a major issue: 62% consider the health system underperforming.
- Among Democratic voters, cuts to Medicaid and subsidies for lower-income populations are primary complaints.
Healthcare is always an issue in state and federal election cycles: states spend 15% of their own money on healthcare programs and 31% of their total spending on healthcare programs which includes Medicaid, CHIP, public health and others. The federal government spends 28% of its budget on healthcare which includes its portion of Medicaid, Medicare, public health and others. (NASBO). And
The Political Context for Healthcare in Elective Politics Today
Traditionally, healthcare issues in election campaigns have centered on three broad sets of issues:
- Coverage and Access: The affordability and terms of participation in public coverage (Medicaid, Medicare, CHIP, Veterans’ Health, et al) and in private insurance purchased individually or through employers. 8% of the population has access to neither.
- Individual Rights: The ability of individuals to access, choose and use private doctors, hospitals and prescription drugs based on individual needs and physician recommendations and limits/constraints imposed by insurers and government regulations.
- Costs and Profits: Healthcare system affordability is a bi-partisan concern: the majority of voters think industry corporatization has put profits above all else, raising prices harmful to consumers while funding wasteful and fraudulent business operations and inexplicable executive compensation. Campaign solutions range from price transparency and controls to public ownership in sectors to increase competition.
In each state, the primary players in the ecosystem are hospitals, physicians and health insurers while public health, long-term care services, mental health services and supply-chain participants (drug companies, device manufacturers, information technologies, retail pharmacies, consultants, accountants and lawyers) play secondary but influential roles. Others—alternative health providers, fitness facilities, social service organizations, free clinics, et al—are role players with lesser influence. Employers are influencers via employee coverage and benefits, and increasingly catalysts for cost-containment. It’s a complicated mass of businesses, government programs and regulatory agencies that account for 18% of the U.S. GDP, 1 in 7 jobs in the U.S. economy and 7.9% of household discretionary spending.
Traditionally, Democratic-leaning and a significant majority of younger voters favor increased access vis a vis subsidized coverage, price controls and more government intervention. They favor restoring Medicaid cuts in HR1 (Big Beautiful Bil) and price controls for hospitals, insurers and prescription drugs. A large and growing number of Democrat-leaning voters think some version of “Medicare for All” is needed without understanding its implication and virtually all believe access to healthcare should be a fundamental right.
By contrast, Republican voters favor less government control, more competition, increased price transparency and anti-fraud measures to remedy an inefficient health system. They believe states are the optimal venues for reforms and market forces including Medicare Advantage key to constraining Medicare spending.
And leaders in both parties concede healthcare affordability is problematic to voters and know public trust and confidence in the health system is low and ignorance of how it operates pervasive. Thus, both parties push voters to believe their candidates have solutions while avoiding specifics. Instead, their candidates deploy focus-group tested rhetoric that resonates with voters without defining what access, affordability and quality actually mean.
Looking Ahead: How Healthcare in Campaign 2026
In the last 29 days of Campaign 2026, four prominent themes will permeate campaign messaging from all sides:
Democratic Campaigns:
- ‘Healthcare is Not Affordable: It’s Big Business dominated by Profit’
- ‘Healthcare Quality is Eroding due to Funding Cuts’
- ‘The Health System is Fundamentally Flawed: Government Intervention is Needed’
- ‘Healthcare is a Fundamental Right: It should be Accessible to All’
- ‘The Big Beautiful Bill’ should be Repealed: Its Medicaid Cuts are Harmful’
Republican Campaigns:
- ‘Price Transparency, Competition and Program Integrity are Keys to Needed Health System Reforms’
- ‘States are Labs for Health System Changes: The Federal Government Should Play a lesser Role (other than protecting Medicare)’
- ‘The Affordable Care Act is Bad Policy: It Costs too Much and Delivered too Little’
- ‘Healthcare Costs are unsustainable adding to the Federal Deficit: Cuts are Needed’
Campaign strategists will advise their clients to lay blame for healthcare problems at the feet of others while promising fresh attention if elected. And candidates will avoid tough questions that expose their lack of understanding of how the system actually operates or intended and unintended consequences of various reforms. Regrettably, journalists will learn little from the candidates themselves, and, instead, receive campaign materials prepared by special interests on their behalf.
Final Thought:
It is anticipated that 47-52% (113 to 125 million) of eligible voters will participate in the election that ends 29 days from today. In 30 days, Campaign 2028 officially starts though fund-raising and exploratory campaigns have already begun.
Affordability issues including healthcare will likely determine winners in both. In response, healthcare organizations must operationalize a new level of transparency that’s necessary as voter expectations mount and Ai-sourced information explodes.
In Campaign 2026, healthcare is on the ballot.
Paul
Sections in today’s report
- Quotables
- Economy
- Hospitals
- Insurers
- Physicians
- Polling
- Population Health
- Prescription Drugs
Quotables
Barnes on Super Intelligence Czar: “it seems that former SEC Chair and former Sullivan & Cromwell partner AI Czar Jay Clayton is leading a big, enthusiastic group of important people with a chance to make everything super. And so quickly! According to President Trump’s announcement of the “Super Intelligence Force,” Czar Clayton has 120 days to explain how to “ensure that America continues to lead the World in Super Intelligence” and “protect the interests and improve the lives” of Americans. After re-branding “artificial intelligence” to “super intelligence” in an Executive Order and getting top executives of AI companies to sign a voluntary accord that would effectively self-police the development of AI technology, it is now up to Czar Clayton to make everything super. Oh, and coordinate the government’s engagement with consumers, public interest groups, religious organizations, infrastructure providers and AI companies about super intelligent things. How super is that?! Without the villainy icky parts, I can imagine Czar Clayton saying something like what Syndrome says in the Incredibles movie: “Oh, come on! You gotta admit, this is cool! Just like a movie: the [AI-controlled] robot will emerge dramatically, do some damage, throngs of screaming people. And just when all hope is lost? Syndrome [Czar Clayton] will save the day!”
Only What Matters on Health Information Policy
Suleyman on AI reasoning: “AIs are not conscious. They do not feel, experience, or suffer. They do not have innate preferences or underlying motivations. They are sequence completion engines, internally hollow, designed to follow instructions, and accomplish goals set by humans.
If humanity is to flourish in the 21st century, that is how they must remain.
Unfortunately, there’s a growing chorus of people who argue that AIs could now be, or may soon become, conscious. They argue that AIs may deserve rights and protections similar to those that we provide other conscious beings. If this view takes hold, it will shake the foundations of our society, rupturing our existing political and ethical frameworks, and fundamentally changing what it means to be human.
Even more importantly, granting rights and imbuing personhood to these systems will make the AI alignment and containment challenge much harder. Controlling something more capable and more intelligent than all of humanity is already an immense challenge, far greater than anything we’ve ever faced. But controlling something that believes it may be conscious – that it’s entitled to our welfare and has rights of its own – may well be impossible.”
A warning about ‘model welfare’
Kenny Powers on reality of the healthcare labor market: “Eventually, people are going to realize the entire economy can’t be carried by all these extremely low paying healthcare jobs, which is where the bulk of what little growth that’s left is concentrated.
Again, that’s not a feeling- Allied Health is a real term that folks outside the industry are mostly unfamiliar with. To be clear, yes administrative bloat is a real problem, but most people associate that with things like health insurance which are actually captured within the finance industry, loosely speaking. And yes, health systems employ folks of various occupations like attorneys, CPAs etc., but the reality is much of the demand for healthcare is on the clinical side, hence allied health workers. As an example, here’s my home state of Tennessee which shows demand for this cohort of providers far outpacing current and future needs. This same trend can be observed at a national level. And yes- it’s a projection, but it’s directionally helpful because allied health providers are one of the largest provider groups depending on how you account for these workers. Of course, operators like utilizing them- they barely pay these people a living wage. Think occupational therapist, physical therapist aide, nurse assistant etc.”
September Jobs Recap – by K. Pow – K.’s Substack
NC Treasurer on Atrium-Wake Consolidation: “Hospital consolidation leads to less competition and higher prices, and I’m not talking about a rural hospital getting acquired when it desperately needs a lifeline to ensure that rural North Carolinians have access to healthcare. I’m referring to when the merger happens as a means of having better market leverage.
I’m echoing the call for Attorney General Jeff Jackson to step in and conduct a thorough, independent assessment of this transaction, its effect on prices, competition and access, and I’m hopeful that federal regulators will step in to consider how cross-market mergers like this one harm competition.”
Health system ‘megamergers’ face growing regulatory scrutiny
Health Affairs commentary on PE limits in healthcare: “A Debate About Tools, Not Just Targets
Taken together, these bills show that Congress’s argument over PE in health care is no longer about whether the industry needs guardrails—both parties have members backing some form of federal response—but about which lever to pull. Given divided government and the difficulty of moving stand-alone health care bills, none of these proposals is likely to become law in the current Congress. But they matter anyway. They signal where CMS rulemaking, state legislatures, and negotiating positions in the next Congress are likely to head, and they force a question policy makers can no longer avoid: not whether PE belongs in health care, but on what terms.”
Congress Weighs How, Not Whether, To Rein In Private Equity In Health Care | Health Affairs
Kahn on measuring value: “Congress should clear away the stumbling blocks in current law and set the pathway: direct payment to reward outcomes, mandate the single measurement platform across payers, establish the measure lifecycle, and require that the calculator question be answered. The framework itself should be built by CMS in open collaboration with the private sector that will live in it — the clinicians, providers, plans, employers, measure developers, and technology vendors whose data and dollars make the system run. The decisions of which outcomes, what adjustment, how governed, and who computes belong to expert hands, and it must be finished before the legislative window opens, not after.
For a quarter century we measured what we could. Now we can measure what matters to medical science and to the patient. A value-based payment system worthy of the name is finally within reach. Reaching it is a choice that belongs to the Congress.”
Buy Right: Key Choices To Getting Value-Based Payment Right | Health Affairs
Cornell Insights Panel on affordability: “According to recent polling, health care affordability ranks as the most important issue facing the country, ahead of the economy, inflation, and immigration. Last year, the average family premium for employer-sponsored insurance increased to nearly $27,000—a 26% increase since 2020. Less than half of Americans say that they can afford access to high-quality care, and about a third say they’ve had to cut back on daily living expenses such as food and utilities to pay for health care.
Many factors have contributed to the growth in health care spending over time, including an aging population, new drugs and technologies, rising administrative costs, heightened provider consolidation, and an increase in commercial health care prices. Policymakers are now considering or have recently introduced a range of proposals intended to improve the affordability of care, but there is considerable uncertainty about whether these policies will achieve their stated aims.”
The Economist on Unnecessary Orthopedic Surgeries: “SIX IN TEN Britons have surgery at some point. So do lots of Americans, at a cost of perhaps $500bn a year, a third of all spending on adults in the world’s biggest health-care market. Plenty of these procedures save lives, by removing tumours, transplanting new organs or mending broken ones. Many others make life better, say by restoring vision (cataract extraction) or hearing (tympanoplasty, for example). Yet a growing body of evidence suggests millions of surgeries performed each year are unnecessary—and, given the risk of complications when a person is sliced open, often worse than useless.
Of ten common orthopaedic procedures, a specialty which accounts for a quarter of all operations in Britain and a similar share in America, only three—for carpal tunnel and total replacement of knees and hips—offer outcomes that are clearly superior to non-operative care. Six, including common ones like lumbar-spine decompression, are no better than drugs, physiotherapy or just Father Time. Similarly, roughly two-thirds of excised appendices could have been fixed with antibiotics and many prostates, around 100,000 of which are operated on in Europe each year, are better off with watchful waiting. The list goes on…
Unlearning decades of modern medical practice will not come easily to health-care systems. It will be harder still for the surgeons. Like all medics, they believe that they are doing right by their patients. But if your only tool is a scalpel, everything looks ripe for cutting.
Jack the knife
Surgeons must therefore be taught, starting in medical school and then by their mentors in what remains an apprenticeship-based craft, to present patients with a range of options and choose the best one together rather than dictating it from on high. Such “shared decision-making” has become common among clinicians but remains alien to many surgeons. It is in everyone’s interest to make it standard.”
Back and shoulder surgery is often worse than useless
Economy
Peterson-KFF: Healthcare job growth: “Job growth in the healthcare sector has been strong in the United States. In recent years, job growth has plateaued across non-health, non-farm sectors, while employment in the health sector continues to grow steadily. In the last year, 378,500 healthcare jobs were added to the economy, a 2% increase, compared to only a 0.2% increase in non-health, non-farm employment during the same time.” Key findings:
- Health care jobs represent 11.7% of all non-farm jobs, up from 10.7% a decade ago.
- Since 1990, health sector employment has grown over three times as much as all other non-health, non-farm employment sectors.
- Health care employment has increased most in outpatient settings, up 40% since August 2016.
- Both health and non-healthcare job openings have fallen to their pre-Covid levels.
- Wage growth of health care employees has slowed slightly compared to other industries over the past three years.
- Wage growth in elderly care and skilled nursing care facilities have increased over 50% since July 2016.
What are the recent trends in health sector employment? – Peterson-KFF Health System Tracker
Altarum Report: Personal health care spending in last 12 months: In July 2026, national health spending grew by 6.8% year over year, down from the revised June 2026 growth rate of 7.1%.
- GDP grew by 6.0% in July, year over year. As a result, national health spending in July equaled 18.4% of GDP. National health spending was most recently below 18% of GDP in July 2024.
- Year-over-year growth in personal health care spending was 6.6% in July, year over year, down from 7.0% in June and 7.5% in July 2025. Utilization growth contributed approximately two-thirds of the increase, with price increases contributing one-third.
- Growth among major spending categories was highest for hospital care, at 8.5%, year over year, while spending for prescription drugs grew the slowest, at 1.3%. Drug spending growth has slowed significantly this year; it stood at 8.0% in July 2025.
- Prescription drug prices continue to decline as overall price growth has slowed in recent months
September 2026 Health Sector Economic Indicators Briefs | Altarum
BLS September 2026 Employment report: “Both the unemployment rate, at 4.%, and the number of unemployed people, at 7.1 million, changed little in September. The unemployment rate has remained in a narrow range of 4.1% to 4.3% since March…
Health care employment continued its upward trend in September (+17,000), but at a slower pace than the average monthly gain over the prior 12 months (+33,000). In September, employment continued to trend up in ambulatory health care services (+13,000) and in hospitals (+12,000), while nursing and residential care facilities lost jobs (-9,000).”
Employment Situation Summary – 2026 M09 Results
Hospitals
NEJM Study: Ai-generated prompts in inpatient care management: “We evaluated the clinical impact of deploying real-time, targeted electronic health record (EHR) alerts and RRT push notifications; the primary outcome was risk-adjusted inhospital mortality.
Results: The study included 23,132 patients. Mean age was 71.9 years, 51.6% were male, and 51.4% were non-Hispanic white. In total, 10,803 patients (46.7%) were preintervention and 12,329 (53.3%) were postintervention; 5746 postintervention encounters (46.6%) generated a push notification to the RRT, although not all resulted in RRT activation. The postintervention group compared with the preintervention group was associated with increased RRT activations (37.5% vs. 25.3%; absolute difference, 12.2 percentage points and decreased unadjusted inhospital mortality (18.6% vs. 23.1%; absolute difference, −4.5 percentage points… Risk-adjusted odds of inhospital mortality, accounting for age, comorbidities, hospital type, EDI score, and clustering at the hospital level were lower in the intervention group (adjusted odds ratio, 0.82 [95% CI, 0.74 to 0.91]).
Conclusions: Implementation of the EDI combined with RRT activation was associated with a reduction in risk-adjusted inpatient mortality across different types of hospitals in a large health system.
Implementation of an AI-Triggered Rapid Response — Association with Mortality | NEJM AI
HRSA announced drug rebate program: Ten drugmakers and 21 drugs will be included in a pilot program to test replacing discounts with rebates under the 340B Drug Pricing Program, the Health Resources and Services Administration announced last week.
Beginning Jan. 1, the agency for the first time will permit pharmaceutical companies to provide post-sale rebates instead of upfront discounts to safety-net providers eligible for reduced pricing. The pilot, which will run at least one year, involves a narrow selection of medicines subject to the Medicare Drug Price Negotiation Program Under the pilot, providers will purchase drugs at wholesale cost, then submit claims data within 45 days to a platform called Beacon to prove the purchased drugs were eligible for rebates. Drugmakers must repay providers within 10 calendar days of submission of a complete claim.
This is HRSA’s second attempt to establish a rebate pilot after the first was legally challenged by the American Hospital Association and later abandoned. Several drug companies previously attempted to institute rebates on their own but were blocked in court.
340B Rebate Model Pilot Program https://www.hrsa.gov/opa/340b-model-pilot-program
CMS on 2027 Medicare Advantage projections: Last week, CMS issued its 2027 MA forecast for the upcoming enrollment period October 15-December 7:
membership will fall from 36.3 million (47.4% of enrollees) this year to 34 million in 2027- the first time since at least 2007 that Medicare Advantage sign-ups decreased.
The total number of Medicare Advantage policies available is essentially flat, falling from 5,553 in 2026 to approximately 5,532 in 2027. More than 99% of eligible enrollees will have access to at least one Medicare Advantage policy, and 97% will be able to choose from at least 10, CMS said. The average Medicare Advantage premium, which includes general enrollment and special needs plan policies, is expected to fall from $14.37 to $12.
Insurers
CMS Issues guidance on 2027 Medicare Advantage, Part D Plans :Last Minday, CMS issued its 2027 guidance:
Medicare Advantage
- The weighted average monthly premium across all MA plans… is projected to decrease from $14.37 in 2026 to $12.00 in 2027, a decline of 16.5%. Supplemental benefit offerings, including hearing, dental, and vision benefits, are expected to remain stable.
- Based on plan projections, enrollment in MA is estimated to be 34 million in 2027, representing approximately 47.4% of all people enrolled in Medicare…
- Access to MA plans remains broad in 2027, with more than 99% of Medicare beneficiaries having access to at least one MA plan, and 97% having access to 10 or more MA plan choices. The total number of available MA plans nationally is expected to remain relatively stable, changing from 5,553 in 2026 to approximately 5,532 in 2027.
Medicare Part D
- The total average monthly Part D premium for stand-alone prescription drug plans is projected to increase less than $1, from $35.09 in 2026 to $36 in 2027. 88% of non-low-income beneficiaries will have access to a basic Part D plan that is $10.30 or less, and 93% of non-low-income beneficiaries will have access to an enhanced Part D plan at less than $6.
- For MA plans that include prescription drug coverage, after application of MA rebates, the average monthly Part D total premium is projected to decrease from $11.32 in 2026 to $7 in 2027, a decrease of $4.32 or 38%.
Medicare Advantage and Medicare Prescription Drug Programs Expected to Remain Stable in 2027 https://www.cms.gov/newsroom/press-releases/medicare-advantage-medicare-prescription-drug-programs-expected-remain-stable-2027
Physicians
JAMA on Medical School growth: Of the 160 LCME-accredited schools, responses were received from 158 (response rate of 99%). Results:
“In 2005-2006, 22.4% of schools had an enrollment of 700 students or more compared with 36.7% of schools in 2025-2026. The enrollment pattern is different for the 30 schools accredited since 2005-2006, none of which had a total enrollment of 700 students or more. illustrates the percentage of students entering medical school who were from the same state as the medical school. In summary, 64.2% of entering students in 2005-2006 were in-state residents compared with 60.8% in 2025-2026. The number of entering medical students (excluding students repeating the year) from the same state as the medical school increased from 10,942 in 2005-2006 to 14,177 in 2025-2026 (an increase of 29.6%). The total number of first-year medical students (excluding students repeating the first year) increased from 17,039 in 2005-2006 to 23,303 in 2025-2026 (an increase of 36.8%). Of the total 20-year increase of 6264 entrants, 2564 (40.9%) came from the 30 schools opened after 2005-2006 and 3700 (59.1%) came from increases in the number of students entering schools that existed before the 2005-2006 academic year.
MD-Granting Medical Schools in the US, 2025-2026 | JAMA | JAMA Network
Polling
Quinnipiac Poll on AI: “Following recent warnings about rogue AI agents, sparking debate over safety versus economic advantage as the U.S. and China race to develop AI systems, 73% of Americans are either very concerned (38%) or somewhat concerned (35%) that future AI systems could potentially threaten human survival, while 25% are either not so concerned (14%) or not concerned at all (11%).
53% of Americans think AI will do more harm than good in their day-to-day lives, while 34 % think AI will do more good than harm in their day-to-day lives, with 13% not offering an opinion. This is little changed from Quinnipiac University’s Poll on AI from March 30, 2026.
Population Health
Cancer Mortality rate: “Overall cancer incidence rates were 504.6 among males and 443.0 among females during 2018–2019/2021–2022. Excluding 2020, cancer incidence rates were stable among males (2013–2022) and increased 0.4% per year among females (2011–2022). Lung cancer incidence decreased 3.5% among males and 1.9% among females per year during 2018–2022. During 2019–2023, overall cancer death rates were 171.5 among males and 126.3 among females, decreasing 1.6% per year among males and 1.1% among females. During this period, lung cancer death rates decreased 4.7% per year among males and 3.0% among females. Since the early 2000s, smoking fell by one half, early diagnosis of lung cancer increased by two thirds, and 5-year relative survival for lung cancer doubled.
Cancer incidence was stable among males but increased slowly among females. Cancer mortality continued to decline, largely because of sustained progress against lung cancer.”
McKinsey on healthy living: Faced with aging populations and a growing burden of preventable diseases, government officials have a transformative opportunity to create healthier, more prosperous societies. Healthy living is no longer only a social objective; it is an economic imperative and a cross-government delivery challenge.
Modifiable health risk factors represent one of the largest untapped opportunities for governments to improve population health while strengthening economic performance. In 2050, eliminating behavioral, metabolic, and environmental risk factors could add 12 years of life expectancy at birth and generate an estimated $16.4 trillion in annual GDP uplift globally, according to a McKinsey Health Institute (MHI) analysis. This is equivalent to nearly 9% of total GDP in 2050.
Some governments are already making healthy living a strategic priority to capture the human and economic benefits of healthier lifespans. In Abu Dhabi, for example, a healthy-living strategy demonstrates how governments could mobilize a broad, cross-government agenda for healthy living. As healthy longevity increasingly becomes a priority around the world, scaling progress will require governments to lead action across the sectors that shape health, supported by stronger evidence, tools, and meaningful opportunities to learn from others.
Healthy living: A $16.4 trillion opportunity | McKinsey
Study: smartphone use and eating disorder relationship: “In this cohort study of 8957 adolescents, 70% of participants owned a smartphone at 12 years of age. Smartphone ownership was cross-sectionally and longitudinally associated with a greater likelihood of experiencing ED symptoms, such as binge eating and tying self-worth to weight.
“Of 8957 participants (4712 [51.8%] male), 6225 (69.5%) owned a smartphone at 12 years of age. Of 6225 participants, the most prevalent ED symptoms were binge-eating symptoms (315 [9.2%]) at 12 years of age and compensatory behaviors (494 [20.5%]) at 14 years of age. In covariate-adjusted analyses, owning a smartphone at 12 years of age was cross-sectionally associated with a higher prevalence of binge-eating symptoms), tying self-worth to weight and any ED symptom.
Conclusions and Relevance: In this cohort study of US adolescents, smartphone ownership was associated with a variety of ED symptoms, suggesting that the timing of smartphone ownership may be associated with ED risk. Future research is needed to characterize the mechanisms underlying these observed associations.”
Prescription Drugs
CMS issues final rule for Globe: The much-scaled back final rule applies to Medicare payments for certain drugs based on what 19 other countries with similar economies pay. the pricing plan will be tested for some patients receiving some of the drugs covered by Medicare Part B—generally expensive drugs that doctors or hospitals administer in person, rather than pills taken at home. Just four manufacturers will be covered under Globe, CMS said in a footnote in the rule.
Globe is expected to save far less money. The administration estimates the program will save $440 million over seven years instead of the $11.9 billion it initially projected.
CMS Finalizes New Mandatory Drug Payment Model to Deliver Lower Drug Prices for Beneficiaries in Original Medicare Part B https://www.cms.gov/newsroom/press-releases/cms-finalizes-new-mandatory-drug-payment-model-deliver-lower-drug-prices-beneficiaries-original
